Western States Cancer Research NCORP: Company Profile

Background

Overview

Western States Cancer Research NCORP (WSCR-NCORP), formerly known as Colorado Cancer Research Program, is a nonprofit organization affiliated with the National Cancer Institute (NCI). Established in 1983, WSCR-NCORP's mission is to provide access to cancer clinical trials and research studies within local communities, enabling patients to participate in cutting-edge research without leaving their hometowns.

Mission and Vision

Mission: To offer the people of Colorado, Washington state, and Alaska the opportunity to participate in and benefit from medical research conducted through cancer clinical trials.

Vision: To keep hope and promise alive by advancing progress through community oncology research.

Primary Area of Focus

WSCR-NCORP focuses on integrating clinical research into community settings, partnering with local physicians, hospitals, and healthcare systems to bring innovative therapies to patients. This approach reduces the administrative burden on providers and enhances patient access to clinical trials.

Industry Significance

As an NCI Community Oncology Research Program (NCORP) Community Site, WSCR-NCORP plays a pivotal role in disseminating cancer research focused on treatment, prevention, symptom control, and cancer care delivery. By collaborating with community-based healthcare providers, the organization ensures that advancements in cancer care are accessible to a broader population.

Key Strategic Focus

Core Objectives

Community Integration: Seamlessly incorporate clinical research into local healthcare practices.

Patient Access: Provide patients with opportunities to participate in clinical trials within their communities.

Provider Support: Offer infrastructure and expertise to healthcare providers, reducing administrative burdens.

Areas of Specialization

Cancer Treatment: Facilitating access to innovative cancer therapies.

Cancer Prevention: Conducting studies aimed at preventing cancer development.

Symptom Control: Researching methods to manage cancer-related symptoms effectively.

Cancer Care Delivery: Improving the delivery of cancer care through research.

Key Technologies Utilized

While specific technologies are not detailed in the available sources, WSCR-NCORP likely employs advanced data management systems and research methodologies to support clinical trials and data analysis.

Primary Markets and Conditions Targeted

WSCR-NCORP primarily serves communities in Colorado, Washington state, and Alaska, focusing on various cancer types and related conditions. By partnering with local healthcare providers, the organization ensures that a diverse patient population has access to clinical trials and research studies.

Financials and Funding

Funding History

As a nonprofit organization, WSCR-NCORP receives funding through government contracts, research studies, contributions, and consortium member income. In the fiscal year ending July 31, 2021, the organization reported total revenues of $1,535,000, with expenses of $1,749,126.

Recent Funding Rounds

Specific details about recent funding rounds are not available in the provided sources.

Notable Investors

As a nonprofit, WSCR-NCORP does not have traditional investors. Funding is primarily sourced from government grants, contributions, and consortium member income.

Intended Utilization of Capital

The capital is utilized to support the organization's mission, including conducting clinical trials, supporting healthcare providers, and advancing cancer research.

Pipeline Development

Key Pipeline Candidates

Specific details about pipeline candidates are not provided in the available sources.

Stages of Clinical Trials or Product Development

WSCR-NCORP facilitates various stages of clinical trials, including treatment, prevention, and symptom control studies. The organization partners with community-based healthcare providers to implement these trials locally.

Target Conditions

The organization focuses on a range of cancer types and related conditions, aiming to improve treatment outcomes and quality of life for patients.

Relevant Timelines for Anticipated Milestones

Specific timelines for anticipated milestones are not detailed in the available sources.

Technological Platform and Innovation

Proprietary Technologies

While specific proprietary technologies are not mentioned, WSCR-NCORP likely utilizes advanced data management systems and research methodologies to support clinical trials and data analysis.

Significant Scientific Methods

The organization employs evidence-based research methodologies to conduct clinical trials, ensuring the reliability and validity of study outcomes.

AI-Driven Capabilities

There is no specific information available regarding the use of AI-driven capabilities within WSCR-NCORP.

Leadership Team

Key Executive Profiles

Dr. Nicholas DiBella: Principal Investigator at WSCR-NCORP, Dr. DiBella is board-certified in medical oncology and hematology. He studied at the University of Southern California School of Medicine and completed his fellowship at Walter Reed Army Medical Center. He has held leadership roles at Fitzsimons Army Medical Center and is a co-founder of Rocky Mountain Cancer Centers.

Leadership Changes

Specific details about recent leadership changes or appointments are not available in the provided sources.

Competitor Profile

Market Insights and Dynamics

The market for community-based cancer clinical trials is growing, with organizations like WSCR-NCORP expanding their reach to provide patients with access to innovative treatments and research studies.

Competitor Analysis

Key competitors include other NCORP Community Sites and Site Management Organizations (SMOs) that integrate clinical research into community healthcare settings. For example, the Nevada NCORP operates in Nevada, Arizona, California, and Washington, bringing clinical trials to local communities.

Strategic Collaborations and Partnerships

WSCR-NCORP collaborates with various healthcare providers and institutions to expand its reach and enhance the delivery of clinical trials. Notably, the organization has partnerships with consortium members across multiple states, including Colorado, Alaska, California, Kentucky, and Washington.

Operational Insights

By partnering with local healthcare providers, WSCR-NCORP differentiates itself by offering community-based access to clinical trials, reducing the need for patients to travel long distances for participation.

Strategic Opportunities and Future Directions

Strategic Roadmap

WSCR-NCORP aims to expand its network of consortium members, enhancing the availability of clinical trials across a broader geographic area. The organization is also focused on increasing patient awareness of alternative treatment options and providing ongoing clinical staff training.

Future Business Directions

The organization plans to broaden its portfolio to include other therapeutic areas, such as behavioral health, dermatology, and urology, in addition to cancer clinical trials.

Opportunities for Expansion

By leveraging its existing partnerships and infrastructure, WSCR-NCORP has the opportunity to extend its services to additional states and communities, further integrating clinical research into local healthcare systems.